Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application/diagnostics

Liquid biopsy (LB) represents an advanced, minimally invasive approach that elevates the precision of oncological decision-making by identifying tumor DNA in bodily fluids. However, despite numerous endorsements from international specialty societies and working groups, implementation of LB into rou...

Full description

Bibliographic Details

Published in:	Journal of Laboratory Medicine
Main Authors:	Gamisch Alexander, Mustafa Hans Georg, Haushofer Alexander, Mustafa-Korninger Maria-Elisabeth
Format:	Article
Language:	English
Published:	De Gruyter 2024-08-01
Subjects:	liquid biopsy liquid profiling molecular diagnostics precision oncology recommendations implementing test strategies
Online Access:	https://doi.org/10.1515/labmed-2024-0029